Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: Athira Pharma(ATHA) the EBIT is -6.874 M (+73.04%);the EPS is -1.68 (+77.54%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.01B73.04%
----
----
EPS
-1.676377.54%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf